Main menu

NCM 2022: Native molecule whole genome sequencing of short fragment cfDNA and FFPE DNA


The Oxford Nanopore Technologies (ONT) sequencing platform is a promising tool in cancer diagnostics because it enables sequencing of DNA molecules of any length. Furthermore, nanopore sequencing can interrogate epigenetic methylation status without any template manipulation, making it valuable for rapid disease classification and sample stratification. Nanopore technology has been largely optimized for long-read sequencing. However, useful templates like cell-free DNA (cfDNA) and DNA derived from formalin-fixed paraffin embedded tissue (FFPE DNA) are highly fragmented.

Download the PDF

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag